Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.

Aditya SharmaGina OdaMark Holodniy

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

BNT162b2 and mRNA-1273 were effective against COVID-19 following emergence of Omicron variant. A third dose provided additional protection over the primary series.

Keyphrases

sars cov
respiratory syndrome coronavirus
randomized controlled trial
coronavirus disease
binding protein
systematic review